| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $917K | +693.5% |
| Cost of Revenue | $527K | +161.9% |
| Gross Profit | $390K | +556.2% |
| R&D Expense | $691K | +45.4% |
| SG&A Expense | $5.0M | +59.5% |
| Operating Income | -$8.7M | -72.7% |
| Pre-tax Income | -$8.7M | -73.8% |
| Net Income | -$8.7M | -73.8% |
| EPS (Basic) | -$0.85 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $475K | -92.2% |
| Accounts Receivable | $87K | +3239.3% |
| Inventory | $370K | +276.6% |
| Current Assets | $1.4M | -78.9% |
| Total Assets | $2.4M | -67.2% |
| Current Liabilities | $1.5M | +23.9% |
| Total Liabilities | $1.7M | +19.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | -62.7% |
| Capital Expenditures | $424K | +175.2% |
| Investing Cash Flow | -$424K | -131.4% |
| Financing Cash Flow | $1.6M | -84.8% |
| Free Cash Flow | -$7.2M | -66.7% |
| -49.1% |
| Stockholders' Equity |
| $725K |
| -87.9% |